
    
      A retrospective, multi-center, chart review study to collect patient data from medical charts
      of patients who have been treated with Korlym® for the treatment of ACTH independent adrenal
      Cushing's Syndrome. Treatment with Korlym® will be a minimum 3 months in duration with
      follow-up of a minimum 3 months. Only sites that have been identified to have patients
      appropriate for this protocol will be invited to participate.
    
  